Lobe Sciences Ltd.
LOBEF
$0.0407
$0.004813.37%
OTC PK
| 05/31/2025 | 02/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.26% | -5.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 68.86% | -5.04% | |||
| Operating Income | -68.86% | 5.04% | |||
| Income Before Tax | -64.28% | 15.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -64.28% | 15.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -42.50% | 15.58% | |||
| EBIT | -68.86% | 5.04% | |||
| EBITDA | -71.17% | 5.07% | |||
| EPS Basic | -38.46% | 23.53% | |||
| Normalized Basic EPS | -10.53% | 9.52% | |||
| EPS Diluted | -38.46% | 23.53% | |||
| Normalized Diluted EPS | -10.53% | 9.52% | |||
| Average Basic Shares Outstanding | 3.43% | 7.29% | |||
| Average Diluted Shares Outstanding | 3.43% | 7.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||